News Focus
News Focus
Followers 17
Posts 3780
Boards Moderated 0
Alias Born 02/21/2009

Re: I-Glow post# 51436

Monday, 03/22/2021 8:11:49 PM

Monday, March 22, 2021 8:11:49 PM

Post# of 64895
Here is what Deitsch has done for NPHC in 19 years:

Added Many patents and trademarks to Nutra's portfolio

Clinical Trials in Multiple Phases

1. Multiple Sclerosis Trials

2. Herpes Simplex Infections 1 & 2 Trials

3. Adrenomyeloneuropathy Trials

4. HIV Trials

5. Amyotrophic Lateral Sclerosis Trials

6. Rheumatoid Arthritis Trials

7. Pain Trials

Products launched and brought to Market

1. Cobroxin

2. Nyloxin

3. Pet Pain Away

4. Equine pain Away

Published Research

http://receptopharm.com/drug_development/published_research.php
https://www.nutrapharma.com/research

Increased Sales on Amazon and Walmart

RPI-78M has received Orphan Drug Designation from the FDA for the treatment of Pediatric Multiple Sclerosis

Huge personal loans from Deitsch to NPHC tells me the CEO knows and believes in NPHC

Truth hurts...Being Short in NPHC hurts even more...

I guess some people have a different definition of accomplished anything!!

he hasn't accomplished anything of value in 19 years



Nyloxin, I put that Sh*t on everything!!! $NPHC

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NPHC News